Drug profile · INN
ramucirumab
CYRAMZA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ramucirumab (CYRAMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ramucirumab
Brand CYRAMZA
Route INJECTION
Formulation INJECTABLE
ATC code L01FX06
Frequently asked questions
What is ramucirumab?
ramucirumab (CYRAMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ramucirumab?
CYRAMZA is a marketed brand name for ramucirumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ramucirumab?
ramucirumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.